Schedule 13G ownership disclosure

OS THERAPIES INCORPORATED

Common Stock, par value $0.001 per share · CUSIP: 68764Y207

Event date: 2026-09-30

Filing-level shares
5,434,150.00
Percent of class
9.9%
  • Thomas A. Satterfield, Jr.

    Shares: 5,434,150.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-125053
Form type
SCHEDULE 13G/A
Filer
OS Therapies Inc
CIK
CIK 1795091
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub